Citation: E. Lindhoff-last et al., Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients, CL APPL T-H, 7(4), 2001, pp. 300-304
Authors:
Lindhoff-Last, E
Gerdsen, F
Ackermann, H
Bauersachs, R
Citation: E. Lindhoff-last et al., Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia, BR J HAEM, 113(4), 2001, pp. 886-890
Authors:
von Lupke, U
Marx, A
Tessmann, R
Lindhoff-Last, E
Citation: U. Von Lupke et al., Danaparoid(Orgaran)as anticoagulant for autotransfusion with Cell Saver 5 (Haemonetics), ANAESTHESIS, 50(1), 2001, pp. 26-31
Authors:
Lindhoff-Last, E
Eichler, P
Stein, M
Plagemann, J
Gerdsen, F
Wagner, R
Ehrly, AM
Bauersachs, R
Citation: E. Lindhoff-last et al., A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery, THROMB RES, 97(6), 2000, pp. 387-393
Authors:
Lindhoff-Last, E
Piechottka, GP
Rabe, F
Bauersachs, R
Citation: E. Lindhoff-last et al., Hirudin determination in plasma can be strongly influenced by the prothrombin level, THROMB RES, 100(1), 2000, pp. 55-60
Authors:
Bauersachs, RM
Lindhoff-Last, E
Ehrly, AM
Citation: Rm. Bauersachs et al., Out-patient treatment of acute pulmonary embolism and fresh proximal deep vein thrombosis with low molecular weight heparin, DEUT MED WO, 124(49), 1999, pp. 1485-1488